Better mouse models of disease: Humanizing experimental atherosclerosis
Better mouse models of disease: Humanizing experimental atherosclerosis
批准号:
8446993
负责人:
Senad Divanovic
金额:
$17.88万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-04-01 至 2015-03-31
关键词:
AddressAdrenergic AgentsAdrenergic ReceptorAffectApolipoprotein EAtherosclerosisAutomobile DrivingBasal metabolic rateBiologicalBiological ModelsBiologyBiomedical ResearchCatecholaminesCellsCholesterolChronicClothingComplexDataDevelopmentDietDiseaseDisease modelExhibitsExperimental ModelsFamilial HypercholesterolemiaFarGoGenerationsGeneticGlucocorticoidsHeart RateHigh Density LipoproteinsHouse miceHousingHumanHuman BiologyImmuneImmunologyInflammationKnock-outLaboratory miceLeadLesionLipidsLipoproteinsLiteratureLow-Density LipoproteinsMacrophage ActivationMetabolicMetabolismModelingMusMyelogenousMyeloid CellsMyocardial InfarctionPathogenesisPatientsPhysiologyPlasmaProductionRare DiseasesReportingResearchResistanceResourcesRestRuptureStagingStressStrokeSympathetic Nervous SystemTechniquesTemperatureTestingTherapeuticThermogenesisTimeTransgenic OrganismsTranslationsUp-RegulationVeinsVery low density lipoproteinWild Type MouseWorkadrenergicbaseblood lipidhigh riskhuman diseasehypercholesterolemiain vivoinattentioninsightmacrophagemonocytemouse modelnovelresearch studyresponsetool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Mice have triumphed as the in vivo experimental model system of choice in biomedical research. However, there are clear limitations to mouse models. The literature is full of therapeutic approaches that worked in mice but failed in humans. Further, mice often provide less than optimal mimics of the human diseases being modeled, atherosclerosis being a prime example. Compared to humans, mice are very resistant to atherosclerosis. In part, this is thought to be due to fundamental differences in lipoprotein metabolism between species. Available mouse models are thus based on dietary or genetic perturbations in lipoprotein metabolism; all have drawbacks. While mouse models have provided important insights into pathogenesis, fundamental biological and practical problems with available models have hindered translation of principles derived from mouse studies to human disease. As with other difficult-to-model diseases, this has been presumed to be due to basic biological differences between species. Indeed, mice are not humans. However, data strongly suggest that the environmental conditions ubiquitously employed in mouse husbandry impair our ability to model atherosclerosis in mice. The studies in this exploratory/developmental proposal address the novel hypothesis that the severe cold stress that laboratory mice are ubiquitously subjected to (a practical "paradigm" employed systematically for nonscientific reasons - the comfort of their clothed human handlers) profoundly affects mouse physiology and immunology in ways that directly impair the modeling of atherosclerosis in mice. Notably, the adaptive response to cold stress involves sustained activation of the sympathetic nervous system and glucocorticoid production, both of which potently suppress the activation of macrophages-cells critical to disease pathogenesis at all stages of atherosclerosis. Furthermore, housing mice in the absence of cold stress has been reported to "humanize" their plasma lipoprotein profiles. The studies in this will thus directly and rapidly test the hypothesis- one strongly supported by data available in the literature - that current mouse models of atherosclerosis are undermined, fundamentally, by the chronic cold stress associated with standard mouse housing conditions. If the hypothesis is correct, this proposal has a clear, important deliverable-the development of a tractable, humanized mouse model of atherosclerosis that would provide a critically needed novel tool for research into atherosclerosis
biology and therapy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Obesity, Metabolic Syndrome and Asthma
-
批准号:9913853
-
项目类别:
-
资助金额:$23.85万
-
财政年份:2019
-
负责人:Senad Divanovic
-
依托单位:
Obesity, Metabolic Syndrome and Asthma
-
批准号:10198401
-
项目类别:
-
资助金额:$10.78万
-
财政年份:2019
-
负责人:Senad Divanovic
-
依托单位:
Immunopathogenesis of non-alcoholic fatty liver disease
-
批准号:10450163
-
项目类别:
-
资助金额:$55.44万
-
财政年份:2013
-
负责人:Senad Divanovic
-
依托单位:
Immunopathogenesis of Non-alcoholic Fatty Liver Disease
-
批准号:8729485
-
项目类别:
-
资助金额:$33.28万
-
财政年份:2013
-
负责人:Senad Divanovic
-
依托单位:
Immunopathogenesis of non-alcoholic fatty liver disease
-
批准号:10223274
-
项目类别:
-
资助金额:$55.44万
-
财政年份:2013
-
负责人:Senad Divanovic
-
依托单位:
Immunopathogenesis of Non-alcoholic Fatty Liver Disease
-
批准号:9115139
-
项目类别:
-
资助金额:$33.28万
-
财政年份:2013
-
负责人:Senad Divanovic
-
依托单位:
Immunopathogenesis of non-alcoholic fatty liver disease
-
批准号:10662241
-
项目类别:
-
资助金额:$55.44万
-
财政年份:2013
-
负责人:Senad Divanovic
-
依托单位:
Immunopathogenesis of non-alcoholic fatty liver disease
-
批准号:10019518
-
项目类别:
-
资助金额:$55.44万
-
财政年份:2013
-
负责人:Senad Divanovic
-
依托单位:
Immunopathogenesis of Non-alcoholic Fatty Liver Disease
-
批准号:8898064
-
项目类别:
-
资助金额:$42.01万
-
财政年份:2013
-
负责人:Senad Divanovic
-
依托单位:
Immunopathogenesis of non-alcoholic fatty liver disease
-
批准号:10158591
-
项目类别:
-
资助金额:$6.78万
-
财政年份:2013
-
负责人:Senad Divanovic
-
依托单位:
Immunopathogenesis of non-alcoholic fatty liver disease
-
批准号:10427752
-
项目类别:
-
资助金额:$6.78万
-
财政年份:2013
-
负责人:Senad Divanovic
-
依托单位:
Immunopathogenesis of Non-alcoholic Fatty Liver Disease
-
批准号:8895814
-
项目类别:
-
资助金额:$8.74万
-
财政年份:2013
-
负责人:Senad Divanovic
-
依托单位:
Immunopathogenesis of Non-alcoholic Fatty Liver Disease
-
批准号:8558364
-
项目类别:
-
资助金额:$33.28万
-
财政年份:2013
-
负责人:Senad Divanovic
-
依托单位:
Immunopathogenesis of Non-alcoholic Fatty Liver Disease
-
批准号:9326991
-
项目类别:
-
资助金额:$33.28万
-
财政年份:2013
-
负责人:Senad Divanovic
-
依托单位:
Better mouse models of disease: Humanizing experimental atherosclerosis
-
批准号:8283784
-
项目类别:
-
资助金额:$24.25万
-
财政年份:2012
-
负责人:Senad Divanovic
-
依托单位:
海外基金